Annual CFO
-$40.80 M
+$12.17 M+22.97%
December 1, 2024
Summary
- As of March 11, 2025, NXTC annual cash flow from operations is -$40.80 million, with the most recent change of +$12.17 million (+22.97%) on December 1, 2024.
- During the last 3 years, NXTC annual CFO has risen by +$16.48 million (+28.77%).
- NXTC annual CFO is now -610.57% below its all-time high of $7.99 million, reached on December 31, 2018.
Performance
NXTC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$6.97 M
+$4.49 M+39.16%
December 1, 2024
Summary
- As of March 11, 2025, NXTC quarterly cash flow from operations is -$6.97 million, with the most recent change of +$4.49 million (+39.16%) on December 1, 2024.
- Over the past year, NXTC quarterly CFO has stayed the same.
- NXTC quarterly CFO is now -131.01% below its all-time high of $22.47 million, reached on December 31, 2018.
Performance
NXTC Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$40.80 M
+$3.70 M+8.32%
December 1, 2024
Summary
- As of March 11, 2025, NXTC TTM cash flow from operations is -$40.80 million, with the most recent change of +$3.70 million (+8.32%) on December 1, 2024.
- Over the past year, NXTC TTM CFO has stayed the same.
- NXTC TTM CFO is now -610.57% below its all-time high of $7.99 million, reached on December 31, 2018.
Performance
NXTC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NXTC Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.0% | 0.0% | 0.0% |
| 3 y3 years | +28.8% | 0.0% | 0.0% |
| 5 y5 years | -14.6% | 0.0% | 0.0% |
NXTC Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +28.8% | at high | +54.9% | at high | +30.6% |
| 5 y | 5-year | -14.6% | +28.8% | -11.0% | +59.5% | -14.6% | +30.6% |
| alltime | all time | -610.6% | +28.8% | -131.0% | +59.5% | -610.6% | +30.6% |
NextCure Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$40.80 M(-23.0%) | -$6.97 M(-39.2%) | -$40.80 M(-8.3%) |
| Sep 2024 | - | -$11.45 M(+17.2%) | -$44.51 M(-2.9%) |
| Jun 2024 | - | -$9.78 M(-22.4%) | -$45.83 M(-9.8%) |
| Mar 2024 | - | -$12.61 M(+18.1%) | -$50.80 M(-4.1%) |
| Dec 2023 | -$52.97 M(-1.7%) | -$10.67 M(-16.5%) | -$52.97 M(+3.4%) |
| Sep 2023 | - | -$12.78 M(-13.4%) | -$51.25 M(-4.2%) |
| Jun 2023 | - | -$14.75 M(-0.2%) | -$53.48 M(+0.5%) |
| Mar 2023 | - | -$14.78 M(+65.1%) | -$53.22 M(-1.2%) |
| Dec 2022 | -$53.89 M(-5.9%) | -$8.95 M(-40.3%) | -$53.89 M(-7.8%) |
| Sep 2022 | - | -$15.00 M(+3.5%) | -$58.42 M(+4.2%) |
| Jun 2022 | - | -$14.49 M(-6.2%) | -$56.09 M(-4.6%) |
| Mar 2022 | - | -$15.45 M(+14.5%) | -$58.82 M(+2.7%) |
| Dec 2021 | -$57.28 M | -$13.49 M(+6.5%) | -$57.28 M(+14.4%) |
| Sep 2021 | - | -$12.66 M(-26.5%) | -$50.07 M(-5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$17.22 M(+23.8%) | -$53.08 M(+10.0%) |
| Mar 2021 | - | -$13.91 M(+121.6%) | -$48.27 M(+7.4%) |
| Dec 2020 | -$44.95 M(+26.2%) | -$6.28 M(-59.9%) | -$44.95 M(-7.6%) |
| Sep 2020 | - | -$15.67 M(+26.3%) | -$48.67 M(+18.9%) |
| Jun 2020 | - | -$12.41 M(+17.1%) | -$40.94 M(+4.6%) |
| Mar 2020 | - | -$10.59 M(+6.0%) | -$39.14 M(+9.9%) |
| Dec 2019 | -$35.62 M(-545.7%) | -$9.99 M(+25.7%) | -$35.62 M(+1027.0%) |
| Sep 2019 | - | -$7.95 M(-25.1%) | -$3.16 M(-4817.9%) |
| Jun 2019 | - | -$10.61 M(+49.8%) | $67.00 K(-98.8%) |
| Mar 2019 | - | -$7.08 M(-131.5%) | $5.71 M(-28.5%) |
| Dec 2018 | $7.99 M(-163.9%) | $22.47 M(-576.2%) | $7.99 M(-155.2%) |
| Sep 2018 | - | -$4.72 M(-4.8%) | -$14.48 M(+48.4%) |
| Jun 2018 | - | -$4.96 M(+3.2%) | -$9.76 M(+103.2%) |
| Mar 2018 | - | -$4.80 M | -$4.80 M |
| Dec 2017 | -$12.51 M | - | - |
FAQ
- What is NextCure annual cash flow from operations?
- What is the all time high annual CFO for NextCure?
- What is NextCure annual CFO year-on-year change?
- What is NextCure quarterly cash flow from operations?
- What is the all time high quarterly CFO for NextCure?
- What is NextCure quarterly CFO year-on-year change?
- What is NextCure TTM cash flow from operations?
- What is the all time high TTM CFO for NextCure?
- What is NextCure TTM CFO year-on-year change?
What is NextCure annual cash flow from operations?
The current annual CFO of NXTC is -$40.80 M
What is the all time high annual CFO for NextCure?
NextCure all-time high annual cash flow from operations is $7.99 M
What is NextCure annual CFO year-on-year change?
Over the past year, NXTC annual cash flow from operations has changed by +$12.17 M (+22.97%)
What is NextCure quarterly cash flow from operations?
The current quarterly CFO of NXTC is -$6.97 M
What is the all time high quarterly CFO for NextCure?
NextCure all-time high quarterly cash flow from operations is $22.47 M
What is NextCure quarterly CFO year-on-year change?
Over the past year, NXTC quarterly cash flow from operations has changed by $0.00 (0.00%)
What is NextCure TTM cash flow from operations?
The current TTM CFO of NXTC is -$40.80 M
What is the all time high TTM CFO for NextCure?
NextCure all-time high TTM cash flow from operations is $7.99 M
What is NextCure TTM CFO year-on-year change?
Over the past year, NXTC TTM cash flow from operations has changed by $0.00 (0.00%)